CELULARITY IMPACT Trademark

Trademark Overview


On Tuesday, May 14, 2019, a trademark application was filed for CELULARITY IMPACT with the United States Patent and Trademark Office. The USPTO has given the CELULARITY IMPACT trademark a serial number of 88429865. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, February 21, 2023. This trademark is owned by Celularity, Inc.. The CELULARITY IMPACT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods

Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells
celularity impact

General Information


Serial Number88429865
Word MarkCELULARITY IMPACT
Filing DateTuesday, May 14, 2019
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, February 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements


Goods and ServicesCells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods
Goods and ServicesCells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, May 30, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelularity Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFlorham Park, NJ 07932

Party NameCelularity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events


Event DateEvent Description
Wednesday, February 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2023SOU EXTENSION 5 GRANTED
Monday, February 13, 2023SOU EXTENSION 5 FILED
Monday, February 13, 2023SOU TEAS EXTENSION RECEIVED
Saturday, August 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 11, 2022SOU EXTENSION 4 GRANTED
Thursday, August 11, 2022SOU EXTENSION 4 FILED
Thursday, August 11, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 15, 2022SOU EXTENSION 3 GRANTED
Tuesday, February 15, 2022SOU EXTENSION 3 FILED
Tuesday, February 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 8, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 16, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, August 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 13, 2021SOU EXTENSION 2 GRANTED
Friday, August 13, 2021SOU EXTENSION 2 FILED
Friday, August 13, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 2, 2021SOU EXTENSION 1 GRANTED
Tuesday, March 2, 2021SOU EXTENSION 1 FILED
Tuesday, March 2, 2021SOU TEAS EXTENSION RECEIVED
Thursday, October 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 16, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 13, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 13, 2020FINAL REFUSAL E-MAILED
Monday, January 13, 2020FINAL REFUSAL WRITTEN
Monday, December 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 31, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2019NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2019NON-FINAL ACTION WRITTEN
Tuesday, July 30, 2019ASSIGNED TO EXAMINER
Thursday, May 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 17, 2019NEW APPLICATION ENTERED